Free Trial
→ URGENT: If you own a home, please review the map below. (From Paradigm Press) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
$1.02
+2.5%		$1.08
$0.76
▼
$2.03
$19.55M1.6737,522 shs1,745 shs
CervoMed Inc. stock logo
CRVO
CervoMed
$1.66
-9.5%		$2.36
$1.27
▼
$10.00
$25.19M-0.621.78 million shs298,717 shs
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
$0.41
+5.5%		$0.46
$0.26
▼
$15.40
$5.38M0.61289,432 shs2,019 shs
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
$1.89
-16.0%		$3.64
$1.90
▼
$7.85
$15.41M1.81154,603 shs190,334 shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
-2.94%-1.10%-8.33%-11.61%-10.00%
CervoMed Inc. stock logo
CRVO
CervoMed
+3.39%+26.21%-19.38%-32.97%-75.30%
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
+14.35%+14.35%-21.50%-23.76%-96.64%
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
-11.42%-4.26%-38.86%-34.59%-70.28%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
$1.02
+2.5%		$1.08
$0.76
▼
$2.03
$19.55M1.6737,522 shs1,745 shs
CervoMed Inc. stock logo
CRVO
CervoMed
$1.66
-9.5%		$2.36
$1.27
▼
$10.00
$25.19M-0.621.78 million shs298,717 shs
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
$0.41
+5.5%		$0.46
$0.26
▼
$15.40
$5.38M0.61289,432 shs2,019 shs
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
$1.89
-16.0%		$3.64
$1.90
▼
$7.85
$15.41M1.81154,603 shs190,334 shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
-2.94%-1.10%-8.33%-11.61%-10.00%
CervoMed Inc. stock logo
CRVO
CervoMed
+3.39%+26.21%-19.38%-32.97%-75.30%
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
+14.35%+14.35%-21.50%-23.76%-96.64%
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
-11.42%-4.26%-38.86%-34.59%-70.28%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
2.00
HoldN/AN/A
CervoMed Inc. stock logo
CRVO
CervoMed
2.71
Moderate Buy$21.001,168.12% Upside
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
2.20
Hold$53.3312,908.13% Upside
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest RVPH, CRVO, TAOX, and COCP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/15/2026
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (D-)
10/9/2026
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy
10/5/2026
CervoMed Inc. stock logo
CRVO
CervoMed
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy
9/3/2026
CervoMed Inc. stock logo
CRVO
CervoMed
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
8/21/2026
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeSell (D-) ➝ Sell (E+)
8/20/2026
CervoMed Inc. stock logo
CRVO
CervoMed
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$7.00
8/13/2026
CervoMed Inc. stock logo
CRVO
CervoMed
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 11/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
N/AN/AN/AN/A$0.46 per shareN/A
CervoMed Inc. stock logo
CRVO
CervoMed
$4.01M6.25N/AN/A$1.15 per share1.44
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
N/AN/AN/AN/A$1.48 per shareN/A
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
$300K50.65N/AN/A$2.83 per share0.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
-$8.83M-$0.76N/AN/AN/AN/A-207.47%-123.33%11/13/2026 (Estimated)
CervoMed Inc. stock logo
CRVO
CervoMed
-$26.97M-$2.77N/AN/AN/AN/A-164.95%-133.71%N/A
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
-$19.86M-$1.85N/AN/AN/AN/A-391.58%-119.08%11/16/2026 (Estimated)
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
-$28.74M-$3.85N/AN/AN/A-2,153.97%-128.51%-97.54%N/A

Latest RVPH, CRVO, TAOX, and COCP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/16/2026Q3 2026
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
-$0.29N/AN/AN/AN/AN/A
11/13/2026N/A
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
-$0.17N/AN/AN/A$0.11 millionN/A
11/9/2026Q3 2026
CervoMed Inc. stock logo
CRVO
CervoMed
-$0.4750-$0.39+$0.0850-$0.39$0.05 millionN/A
8/13/2026Q2 2026
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
-$0.17-$0.23-$0.06-$0.23$0.11 million$0.11 million
8/13/2026Q2 2026
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
-$0.3850-$0.19+$0.1950N/AN/AN/A
8/13/2026Q2 2026
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
N/A-$1.83N/A-$1.83N/A$0.09 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
N/AN/AN/AN/AN/A
CervoMed Inc. stock logo
CRVO
CervoMed
N/AN/AN/AN/AN/A
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
N/AN/AN/AN/AN/A
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
N/A
1.24
1.24
CervoMed Inc. stock logo
CRVO
CervoMed
N/A
5.37
8.57
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
N/A
2.08
2.08
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
N/A
19.98
19.98

Institutional Ownership

CompanyInstitutional Ownership
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
6.72%
CervoMed Inc. stock logo
CRVO
CervoMed
25.15%
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
63.18%
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
10.34%

Insider Ownership

CompanyInsider Ownership
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
39.40%
CervoMed Inc. stock logo
CRVO
CervoMed
35.80%
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
8.90%
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
2.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
1019.26 million11.67 millionNot Optionable
CervoMed Inc. stock logo
CRVO
CervoMed
1515.13 million9.71 millionNot Optionable
Reviva Pharmaceuticals Holdings, Inc. stock logo
RVPH
Reviva Pharmaceuticals
1413.11 million11.67 millionNo Data
Synaptogenix, Inc. stock logo
TAOX
Synaptogenix
48.04 million7.83 millionN/A

Recent News About These Companies

Synaptogenix (NASDAQ:TAOX) Stock Price Down 11% - Here's What Happened
November 3, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31174906
TAO Synergies Appoints Bittensor Investor and Author Mark Jeffrey as Advisor
July 8, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-appoints-bittensor-investor-and-author-mark-jeffrey-as-advisor-302820337.html
TAO Synergies Set to Join the Russell Microcap® Index as a Leading Public Gateway to Decentralized AI
June 16, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-set-to-join-the-russell-microcap-index-as-a-leading-public-gateway-to-decentralized-ai-302801330.html
TAO Synergies and Yuma Asset Management to Host Livestream on X: Bittensor (TAO) and DeAI Innovation
November 18, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-and-yuma-asset-management-to-host-livestream-on-x-bittensor-tao-and-deai-innovation-302618425.html
Tradr Set to Debut ETFs Targeting Bloom Energy, Celestica, Nano Nuclear and Synopsys
November 11, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tradr-set-to-debut-etfs-targeting-bloom-energy-celestica-nano-nuclear-and-synopsys-302611818.html
TAO Synergies Announces Initial $750,000 Investment in Yuma Asset Management's Subnet Funds
November 4, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-announces-initial-750-000-investment-in-yuma-asset-managements-subnet-funds-302603960.html
TAO Synergies Raises Bittensor (TAO) Holdings to over 54,000 Tokens, Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency
October 20, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-raises-bittensor-tao-holdings-to-over-54-000-tokens-largest-publicly-traded-holder-of-top-decentralized-ai-cryptocurrency-302589032.html
TAO Synergies Announces $11 Million Private Placement
October 13, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-announces-11-million-private-placement-302582503.html
TAO Synergies Launches "The TAO Daily," the Premier Media Platform for All Things Bittensor (TAO)
September 22, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-launches-the-tao-daily-the-premier-media-platform-for-all-things-bittensor-tao-302562601.html
TAO Synergies Digital Assets Advisor James Altucher Speaks at Google's Planet Scale Consumer AI Event
September 8, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-digital-assets-advisor-james-altucher-speaks-at-googles-planet-scale-consumer-ai-event-302548971.html
TAO Synergies (Formerly Synaptogenix) Begins Trading Under New Nasdaq Stock Symbol "TAOX" Effective at Market Open Today
July 1, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tao-synergies-formerly-synaptogenix-begins-trading-under-new-nasdaq-stock-symbol-taox-effective-at-market-open-today-302495716.html
Synaptogenix Announces Name Change to TAO Synergies and New Ticker Symbol "TAOX" for Alignment with AI-Focused Crypto Treasury Strategy
June 26, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/synaptogenix-announces-name-change-to-tao-synergies-and-new-ticker-symbol-taox-for-alignment-with-ai-focused-crypto-treasury-strategy-302491852.html
Synaptogenix Announces Initial TAO Acquisition under Crypto Treasury Strategy, Appoints BitGo as Custodian, and Commences Yield Generation Through Staking - KXAN Austin
June 26, 2025  |  kxan.comK
Synaptogenix begins TAO acquisition as part of crypto treasury strategy
June 26, 2025  |  uk.investing.comhttps://uk.investing.com/news/company-news/synaptogenix-begins-tao-acquisition-as-part-of-crypto-treasury-strategy-93CH-4144284
Synaptogenix Announces Initial TAO Acquisition under Crypto Treasury Strategy, Appoints BitGo as Custodian, and Commences Yield Generation Through Staking - KTLA
June 26, 2025  |  ktla.comK
Synaptogenix Announces Initial TAO Acquisition under Crypto Treasury Strategy, Appoints BitGo as Custodian, and Commences Yield Generation Through Staking
June 24, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/synaptogenix-announces-initial-tao-acquisition-under-crypto-treasury-strategy-appoints-bitgo-as-custodian-and-commences-yield-generation-through-staking-302489342.html
Synaptogenix Unveils TAO-Focused Crypto Treasury Plan
June 10, 2025  |  livebitcoinnews.comL
Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token
June 9, 2025  |  prnewswire.comhttps://www.prnewswire.com/news-releases/synaptogenix-appoints-crypto-expert-to-lead-digital-asset-treasury-strategy-focused-exclusively-on-top-valued-ai-token-302476176.html
Synaptogenix Inc Ordinary Shares
January 3, 2025  |  morningstar.comM
Synaptogenix Board of Directors Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength
December 20, 2024  |  prnewswire.comhttps://www.prnewswire.com/news-releases/synaptogenix-board-of-directors-forms-special-committee-to-explore-value-creation-opportunities-utilizing-balance-sheet-strength-302336765.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cocrystal Pharma stock logo

Cocrystal Pharma NASDAQ:COCP

$1.01 +0.03 (+2.53%)
As of 11:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.

CervoMed stock logo

CervoMed NASDAQ:CRVO

$1.66 -0.17 (-9.51%)
As of 11:35 AM Eastern
This is a fair market value price provided by Massive. Learn more.

CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery. The company also develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

Reviva Pharmaceuticals stock logo

Reviva Pharmaceuticals NASDAQ:RVPH

$0.41 +0.02 (+5.45%)
As of 11:04 AM Eastern

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of various neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. Reviva Pharmaceuticals Holdings, Inc. was founded in 2018 and is headquartered in Cupertino, California.

Synaptogenix stock logo

Synaptogenix NASDAQ:TAOX

$1.89 -0.36 (-16.00%)
As of 11:36 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas